טוען...
International clinical trials setting for rare cancers: organisational and regulatory constraints—the EORTC perspective
Rare diseases are a serious public health problem that presents unique challenges to many countries. There is no internationally accepted definition for rare diseases. Patients suffering from rare cancers often face challenges, including late or incorrect diagnoses, difficulties finding clinical exp...
שמור ב:
| Main Authors: | , , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Cancer Intelligence
2013
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3660157/ https://ncbi.nlm.nih.gov/pubmed/23717342 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3332/ecancer.2013.321 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|